Phosphorylated CCAAT/enhancer binding protein β Contributes to rat HIV-related neuropathic pain

In vitro and in vivo studies

Hyun Yi, Shue Liu, Yuta Kashiwagi, Daigo Ikegami, Wan Huang, Hirotsugu Kanda, Takafumi Iida, Ching Hang Liu, Keiya Takahashi, David Lubarsky, Shuanglin Hao

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Chronic pain is increasingly recognized as an important comorbidity of HIV-infected patients, however, the exact molecular mechanisms of HIV-related pain are still elusive. CCAAT/enhancer binding proteins (C/EBPs) are expressed in various tissues, including the CNS. C/EBPβ, one of the C/EBPs, is involved in the progression of HIV/AIDS, but the exact role of C/EBPβ and its upstream factors are not clear in HIV pain state. Here, we used a neuropathic pain model of perineural HIV envelope glycoprotein gp120 application onto the rat sciatic nerve to test the role of phosphorylated C/EBPβ (pC/EBPβ) and its upstream pathway in the spinal cord dorsal horn (SCDH). HIV gp120 induced overexpression of pC/EBPβ in the ipsilateral SCDH compared with contralateral SCDH. Inhibition of C/EBPβ using siRNA against C/EBPβ reduced mechanical allodynia. HIV gp120 also increased TNFα, TNFRI, mitochondrial superoxide (mtO2 .-), and pCREB in the ipsilateral SCDH. ChIP-qPCR assay showed that pCREB enrichment on the C/EBPβ gene promoter regions in rats with gp120 was higher than that in sham rats. Intrathecal TNF soluble receptor I (functionally blocking TNFα bioactivity) or knockdown of TNFRI using antisense oligodeoxynucleotide against TNFRI reduced mechanical allodynia, and decreased mtO.- 2, pCREB and pC/EBPβ. Intrathecal Mito-tempol (amitochondria-targetedO2 .-scavenger) reduced mechanical allodynia and decreased pCREB and pC/EBPβ. Knock down of CREB with antisense oligodeoxynucleotide against CREB reduced mechanical allodynia and lowered pC/EBPβ. These results suggested that the pathway of TNFα/TNFRI–mtO.- 2 –pCREB triggers pC/EBPβ in the HIV gp120-induced neuropathic pain state. Furthermore, we confirmed the pathway using both cultured neurons treated with recombinant TNFαin vitro and repeated intrathecal injection of recombinant TNFαin naive rats. This finding provides new insights in the understanding of the HIV neuropathic pain mechanisms and treatment.

Original languageEnglish (US)
Pages (from-to)555-574
Number of pages20
JournalJournal of Neuroscience
Volume38
Issue number3
DOIs
StatePublished - Jan 17 2018

Fingerprint

CCAAT-Enhancer-Binding Proteins
Neuralgia
HIV Envelope Protein gp120
HIV
Hyperalgesia
Oligodeoxyribonucleotides
Pain
Spinal Injections
In Vitro Techniques
Tumor Necrosis Factor Receptors
Sciatic Nerve
Genetic Promoter Regions
Superoxides
Chronic Pain
Small Interfering RNA
Comorbidity
Acquired Immunodeficiency Syndrome
Neurons
Spinal Cord Dorsal Horn

Keywords

  • Epigenetics
  • HIV pain
  • Mitochondrial superoxide
  • pC/EBPβ
  • pCREB
  • TNFα

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Phosphorylated CCAAT/enhancer binding protein β Contributes to rat HIV-related neuropathic pain : In vitro and in vivo studies. / Yi, Hyun; Liu, Shue; Kashiwagi, Yuta; Ikegami, Daigo; Huang, Wan; Kanda, Hirotsugu; Iida, Takafumi; Liu, Ching Hang; Takahashi, Keiya; Lubarsky, David; Hao, Shuanglin.

In: Journal of Neuroscience, Vol. 38, No. 3, 17.01.2018, p. 555-574.

Research output: Contribution to journalArticle

Yi, H, Liu, S, Kashiwagi, Y, Ikegami, D, Huang, W, Kanda, H, Iida, T, Liu, CH, Takahashi, K, Lubarsky, D & Hao, S 2018, 'Phosphorylated CCAAT/enhancer binding protein β Contributes to rat HIV-related neuropathic pain: In vitro and in vivo studies', Journal of Neuroscience, vol. 38, no. 3, pp. 555-574. https://doi.org/10.1523/JNEUROSCI.3647-16.2017
Yi, Hyun ; Liu, Shue ; Kashiwagi, Yuta ; Ikegami, Daigo ; Huang, Wan ; Kanda, Hirotsugu ; Iida, Takafumi ; Liu, Ching Hang ; Takahashi, Keiya ; Lubarsky, David ; Hao, Shuanglin. / Phosphorylated CCAAT/enhancer binding protein β Contributes to rat HIV-related neuropathic pain : In vitro and in vivo studies. In: Journal of Neuroscience. 2018 ; Vol. 38, No. 3. pp. 555-574.
@article{9142eb2abc314f6aa1f4ddb4aeb5c76c,
title = "Phosphorylated CCAAT/enhancer binding protein β Contributes to rat HIV-related neuropathic pain: In vitro and in vivo studies",
abstract = "Chronic pain is increasingly recognized as an important comorbidity of HIV-infected patients, however, the exact molecular mechanisms of HIV-related pain are still elusive. CCAAT/enhancer binding proteins (C/EBPs) are expressed in various tissues, including the CNS. C/EBPβ, one of the C/EBPs, is involved in the progression of HIV/AIDS, but the exact role of C/EBPβ and its upstream factors are not clear in HIV pain state. Here, we used a neuropathic pain model of perineural HIV envelope glycoprotein gp120 application onto the rat sciatic nerve to test the role of phosphorylated C/EBPβ (pC/EBPβ) and its upstream pathway in the spinal cord dorsal horn (SCDH). HIV gp120 induced overexpression of pC/EBPβ in the ipsilateral SCDH compared with contralateral SCDH. Inhibition of C/EBPβ using siRNA against C/EBPβ reduced mechanical allodynia. HIV gp120 also increased TNFα, TNFRI, mitochondrial superoxide (mtO2 .-), and pCREB in the ipsilateral SCDH. ChIP-qPCR assay showed that pCREB enrichment on the C/EBPβ gene promoter regions in rats with gp120 was higher than that in sham rats. Intrathecal TNF soluble receptor I (functionally blocking TNFα bioactivity) or knockdown of TNFRI using antisense oligodeoxynucleotide against TNFRI reduced mechanical allodynia, and decreased mtO.- 2, pCREB and pC/EBPβ. Intrathecal Mito-tempol (amitochondria-targetedO2 .-scavenger) reduced mechanical allodynia and decreased pCREB and pC/EBPβ. Knock down of CREB with antisense oligodeoxynucleotide against CREB reduced mechanical allodynia and lowered pC/EBPβ. These results suggested that the pathway of TNFα/TNFRI–mtO.- 2 –pCREB triggers pC/EBPβ in the HIV gp120-induced neuropathic pain state. Furthermore, we confirmed the pathway using both cultured neurons treated with recombinant TNFαin vitro and repeated intrathecal injection of recombinant TNFαin naive rats. This finding provides new insights in the understanding of the HIV neuropathic pain mechanisms and treatment.",
keywords = "Epigenetics, HIV pain, Mitochondrial superoxide, pC/EBPβ, pCREB, TNFα",
author = "Hyun Yi and Shue Liu and Yuta Kashiwagi and Daigo Ikegami and Wan Huang and Hirotsugu Kanda and Takafumi Iida and Liu, {Ching Hang} and Keiya Takahashi and David Lubarsky and Shuanglin Hao",
year = "2018",
month = "1",
day = "17",
doi = "10.1523/JNEUROSCI.3647-16.2017",
language = "English (US)",
volume = "38",
pages = "555--574",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "3",

}

TY - JOUR

T1 - Phosphorylated CCAAT/enhancer binding protein β Contributes to rat HIV-related neuropathic pain

T2 - In vitro and in vivo studies

AU - Yi, Hyun

AU - Liu, Shue

AU - Kashiwagi, Yuta

AU - Ikegami, Daigo

AU - Huang, Wan

AU - Kanda, Hirotsugu

AU - Iida, Takafumi

AU - Liu, Ching Hang

AU - Takahashi, Keiya

AU - Lubarsky, David

AU - Hao, Shuanglin

PY - 2018/1/17

Y1 - 2018/1/17

N2 - Chronic pain is increasingly recognized as an important comorbidity of HIV-infected patients, however, the exact molecular mechanisms of HIV-related pain are still elusive. CCAAT/enhancer binding proteins (C/EBPs) are expressed in various tissues, including the CNS. C/EBPβ, one of the C/EBPs, is involved in the progression of HIV/AIDS, but the exact role of C/EBPβ and its upstream factors are not clear in HIV pain state. Here, we used a neuropathic pain model of perineural HIV envelope glycoprotein gp120 application onto the rat sciatic nerve to test the role of phosphorylated C/EBPβ (pC/EBPβ) and its upstream pathway in the spinal cord dorsal horn (SCDH). HIV gp120 induced overexpression of pC/EBPβ in the ipsilateral SCDH compared with contralateral SCDH. Inhibition of C/EBPβ using siRNA against C/EBPβ reduced mechanical allodynia. HIV gp120 also increased TNFα, TNFRI, mitochondrial superoxide (mtO2 .-), and pCREB in the ipsilateral SCDH. ChIP-qPCR assay showed that pCREB enrichment on the C/EBPβ gene promoter regions in rats with gp120 was higher than that in sham rats. Intrathecal TNF soluble receptor I (functionally blocking TNFα bioactivity) or knockdown of TNFRI using antisense oligodeoxynucleotide against TNFRI reduced mechanical allodynia, and decreased mtO.- 2, pCREB and pC/EBPβ. Intrathecal Mito-tempol (amitochondria-targetedO2 .-scavenger) reduced mechanical allodynia and decreased pCREB and pC/EBPβ. Knock down of CREB with antisense oligodeoxynucleotide against CREB reduced mechanical allodynia and lowered pC/EBPβ. These results suggested that the pathway of TNFα/TNFRI–mtO.- 2 –pCREB triggers pC/EBPβ in the HIV gp120-induced neuropathic pain state. Furthermore, we confirmed the pathway using both cultured neurons treated with recombinant TNFαin vitro and repeated intrathecal injection of recombinant TNFαin naive rats. This finding provides new insights in the understanding of the HIV neuropathic pain mechanisms and treatment.

AB - Chronic pain is increasingly recognized as an important comorbidity of HIV-infected patients, however, the exact molecular mechanisms of HIV-related pain are still elusive. CCAAT/enhancer binding proteins (C/EBPs) are expressed in various tissues, including the CNS. C/EBPβ, one of the C/EBPs, is involved in the progression of HIV/AIDS, but the exact role of C/EBPβ and its upstream factors are not clear in HIV pain state. Here, we used a neuropathic pain model of perineural HIV envelope glycoprotein gp120 application onto the rat sciatic nerve to test the role of phosphorylated C/EBPβ (pC/EBPβ) and its upstream pathway in the spinal cord dorsal horn (SCDH). HIV gp120 induced overexpression of pC/EBPβ in the ipsilateral SCDH compared with contralateral SCDH. Inhibition of C/EBPβ using siRNA against C/EBPβ reduced mechanical allodynia. HIV gp120 also increased TNFα, TNFRI, mitochondrial superoxide (mtO2 .-), and pCREB in the ipsilateral SCDH. ChIP-qPCR assay showed that pCREB enrichment on the C/EBPβ gene promoter regions in rats with gp120 was higher than that in sham rats. Intrathecal TNF soluble receptor I (functionally blocking TNFα bioactivity) or knockdown of TNFRI using antisense oligodeoxynucleotide against TNFRI reduced mechanical allodynia, and decreased mtO.- 2, pCREB and pC/EBPβ. Intrathecal Mito-tempol (amitochondria-targetedO2 .-scavenger) reduced mechanical allodynia and decreased pCREB and pC/EBPβ. Knock down of CREB with antisense oligodeoxynucleotide against CREB reduced mechanical allodynia and lowered pC/EBPβ. These results suggested that the pathway of TNFα/TNFRI–mtO.- 2 –pCREB triggers pC/EBPβ in the HIV gp120-induced neuropathic pain state. Furthermore, we confirmed the pathway using both cultured neurons treated with recombinant TNFαin vitro and repeated intrathecal injection of recombinant TNFαin naive rats. This finding provides new insights in the understanding of the HIV neuropathic pain mechanisms and treatment.

KW - Epigenetics

KW - HIV pain

KW - Mitochondrial superoxide

KW - pC/EBPβ

KW - pCREB

KW - TNFα

UR - http://www.scopus.com/inward/record.url?scp=85040805921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040805921&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.3647-16.2017

DO - 10.1523/JNEUROSCI.3647-16.2017

M3 - Article

VL - 38

SP - 555

EP - 574

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 3

ER -